Groundbreaking Lymphatic Interventions and Drug Exploration
Closed Posted
- Opportunity number
- ARPA-H-SOL-24-111
- Applications due
- Award size
- Up to $50,000,000
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement, Other
- Category
-
- Science and Technology and other Research and Development
- Eligible applicants
-
- Small Businesses
- For Profit Organizations
- Individuals
- 501(c)(3) Nonprofits
- Non-501(c)(3) Nonprofits
- Higher Education Inst. (Public)
- Higher Education Inst. (Private)
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Advanced Research Projects Agency for Health (ARPA-H) is seeking proposals for the Groundbreaking Lymphatic Interventions and Drug Exploration (GLIDE) program. The GLIDE program aims to develop a portfolio of physical devices and pharmacologic, genetic, and cell therapeutics to address lymphatic dysfunction through decompression of obstructed flow and normalization of lymphatic function. Proposals must be submitted under one of two technical areas: TA1 for physical interventions or TA2 for pharmacologic, gene, and cell therapies. Applicants must designate their approach as either an "Activator" or "Accelerator" pathway based on the technical readiness of the proposed solution. Key requirements include developing data management and sharing plans, addressing accessibility and health equity, and achieving specific performance targets related to lymphatic function. Proposals are due by December 12, 2024.
ARPA-H anticipates awarding multiple Other Transaction Agreements and Cooperative Agreements for this program. Funding targets range from $250-$8,000 for devices and under $10,000 for therapeutic cures. The program timeline is up to 36 months for the Activator pathway or up to 18 months for the Accelerator pathway, with potential additional phases.
Synopsis
2 versions
Update #2 · Latest ·
The Advanced Research Projects Agency for Health (ARPA-H) is posting this FINAL Innovative Solutions Opening (ISO) ARPA-H-SOL-24-111 for the Groundbreaking Lymphatic Interventions and Drug Exploration (GLIDE) Program. Attachments 1, 2, 3a, and 3b are included. Information in the full ISO supersedes any information presented in the draft ISO, Proposers' Day slides and presentations, and any other publications.
Update #1 ·
The Advanced Research Projects Agency for Health (ARPA-H) is posting this DRAFT Innovative Solutions Opening (ISO) ARPA-H-SOL-24-111 for the Groundbreaking Lymphatic Interventions and Drug Exploration (GLIDE) Program in order to help potential proposers prepare for Proposer's Day and plan for solution summary submission.
The finalized ISO and related attachments will be posted at a later date.
The Special Notice for GLIDE Proposers' Day (ARPA-H-SN-24-112) can be found at https://sam.gov/opp/e5a145b4c98c468189523e815b69d069/view
Files
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity